NASDAQ:XYLO • US58471G5080
The current stock price of XYLO is 5.07 USD. In the past month the price decreased by -0.98%. In the past year, price increased by 40.44%.
ChartMill assigns a technical rating of 5 / 10 to XYLO. When comparing the yearly performance of all stocks, XYLO is one of the better performing stocks in the market, outperforming 78.82% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to XYLO. Both the profitability and financial health of XYLO have multiple concerns.
Over the last trailing twelve months XYLO reported a non-GAAP Earnings per Share(EPS) of -3.46. The EPS increased by 66.37% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -16.05% | ||
| ROE | -33.51% | ||
| Debt/Equity | 0.07 |
For the next year, analysts expect an EPS growth of 1216.67% and a revenue growth 5.71% for XYLO
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.54 | 195.084B | ||
| ISRG | INTUITIVE SURGICAL INC | 49.31 | 177.398B | ||
| SYK | STRYKER CORP | 25.15 | 142.513B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.29 | 112.294B | ||
| BDX | BECTON DICKINSON AND CO | 11.77 | 51.988B | ||
| IDXX | IDEXX LABORATORIES INC | 42.9 | 50.364B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.83 | 45.797B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.77 | 37.832B | ||
| RMD | RESMED INC | 21.1 | 37.336B | ||
| DXCM | DEXCOM INC | 28.94 | 28.187B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Xylo Technologies Ltd. is a technology-based company, which engages in advancing innovative solutions for large-scale market applications. The firm developed a range of micro video cameras under micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD).
XYLO TECHNOLOGIES LTD
7A Industrial Park,, P.O. Box 3030
OMER IL
Employees: 38
Phone: 97286466880
Xylo Technologies Ltd. is a technology-based company, which engages in advancing innovative solutions for large-scale market applications. The firm developed a range of micro video cameras under micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD).
The current stock price of XYLO is 5.07 USD.
XYLO does not pay a dividend.
XYLO has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
XYLO TECHNOLOGIES LTD (XYLO) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
XYLO TECHNOLOGIES LTD (XYLO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.46).
XYLO TECHNOLOGIES LTD (XYLO) has a market capitalization of 9.61M USD. This makes XYLO a Nano Cap stock.